Antitumour Activity of the Poly(Adp-Ribose) Polymerase (Parp) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (Crpc) in the Toparp Trial
dc.contributor.author | Sandhu, S | |
dc.contributor.author | Mateo, J | |
dc.contributor.author | Miranda, S | |
dc.contributor.author | Carreira, S | |
dc.contributor.author | Jain, S | |
dc.contributor.author | Ralph, C | |
dc.contributor.author | Protheroe, A | |
dc.contributor.author | Hussain, S | |
dc.contributor.author | Jones, R | |
dc.contributor.author | Elliott, Tony | |
dc.contributor.author | McGovern, U | |
dc.contributor.author | Gillman, A | |
dc.contributor.author | Paulding, C | |
dc.contributor.author | Mossop, H | |
dc.contributor.author | Porta, N | |
dc.contributor.author | Bianchini, D | |
dc.contributor.author | Zafeiriou, Z | |
dc.contributor.author | Boysen, G | |
dc.contributor.author | Rodrigues, D | |
dc.contributor.author | Flohr, P | |
dc.contributor.author | Seed, G | |
dc.contributor.author | Goodal, J | |
dc.contributor.author | Figueiredo, I | |
dc.contributor.author | Perez-Lopez, R | |
dc.contributor.author | Tunariu, N | |
dc.contributor.author | Omlin, A | |
dc.contributor.author | Ferraldeschi, R | |
dc.contributor.author | Kunju, L | |
dc.contributor.author | Eeles, R | |
dc.contributor.author | Attard, G | |
dc.contributor.author | Robinson, D | |
dc.contributor.author | Chinnaiyan, A | |
dc.contributor.author | Hall, E | |
dc.contributor.author | De Bono, J | |
dc.contributor.author | Elliott, Tony | |
dc.date.accessioned | 2016-01-06T10:08:20Z | en |
dc.date.available | 2016-01-06T10:08:20Z | en |
dc.date.issued | 2015 | en |
dc.identifier.citation | Antitumour Activity of the Poly(Adp-Ribose) Polymerase (Parp) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (Crpc) in the Toparp Trial. 2015, 11 28-29 Asia Pac J Clin Oncol | en |
dc.identifier.uri | http://hdl.handle.net/10541/592910 | en |
dc.language.iso | en | en |
dc.title | Antitumour Activity of the Poly(Adp-Ribose) Polymerase (Parp) Inhibitor Olaparib in Unselected Sporadic Castration Resistant Prostate Cancer (Crpc) in the Toparp Trial | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | Peter Macmillan Cancer Centre, East Melbourne, Vic, Australia | en |
dc.identifier.journal | Asia-Pacific Journal of Clinical Oncology | en |